ESC 365 - OR 09 - Istaroxime follow-on compounds: a new class of selective SERCA2a activators as first-in-class drug candidates for heart failure treatment

Open Access

OR 09 - Istaroxime follow-on compounds: a new class of selective SERCA2a activators as first-in-class drug candidates for heart failure treatment

Session: Session 4: Pharmacology of Ion Channels

Topic: Cellular Electrophysiology

Speaker: Mrs M. Arici (Milan, IT)

Event: 47th EWGCCE Meeting 2023

Seminar Presentation

Add to my library

About the speaker

Mrs Martina Arici

University of Milan Bicocca, Milan (Italy)

1 presentation

0 follower

4 more presentations in this session

Atrial hiPSC as a pharmacological model for human atrium

Speaker: Doctor T. Christ (Hamburg, DE)

OR 10 - Interventricular differences in the contribution of TREK-1 to cardiac action potential in mice

OR 11 - In vivo KCNQ1-suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome

Speaker: Ms L. Giammarino (Bern, CH)

OR 12 - The effects of ABT-333 (dasabuvir) on the electrophysiology of the canine left ventricular cardiomyocytes and expressed hERG channels

Speaker: Mr Z. Kovacs (HU)

Access the full session

Session 4: Pharmacology of Ion Channels

Speakers: Mrs M. Arici, Doctor T. Christ, Ms L. Giammarino, Mr Z. Kovacs

About the event

47th EWGCCE Meeting 2023

12 June - 14 June 2023

Seminar

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources